B3B-17383-33287
2 vaccinations
5 coded responses
23 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 21-25
- ZIP prefix
- 554 / MN
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Registered in v-safe
-
2021-03-15
Dose 1 — Pfizer-BioNTech
- 2021-03-15
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-18
- 2021-03-19
- 2021-03-20
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-22
-
2021-03-29
Survey response — day 14, dose 1MedDRA: Fatigue, Myalgia, Sleep disorder — Feeling: FairFree text: Increased fatigue and muscle soreness. Trouble sleeping.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Dose 2 — Pfizer-BioNTech
- 2021-04-05
-
2021-04-06
Survey response — days 1–6 daily, dose 2MedDRA: Clumsiness, Disorientation — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Disoriented, unusually clumsyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
-
2021-04-19
Survey response — day 14, dose 2MedDRA: Abdominal pain upper, Disturbance in attention, Headache, Insomnia, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: The last few days I was feeling increasingly nauseous with headaches and stomachache. Trouble sleeping and lack of focus.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
-
2021-05-03
Survey response — day 28, dose 2MedDRA: Diarrhoea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: DiarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-10
- 2021-05-17
- 2021-07-05
-
2021-10-04
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia, Chills, Cough, Headache, Mobility decreased, Oropharyngeal pain, Pain, Patient isolation, Pyrexia, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I got tested positive for COVID-19, but have finished my 10 day isolation period. Day 3 was the worst, I woke up with chills and a cough, I could barely move. Headache and body aches, feverish, sore throat, fatigued, loss of taste and smell.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-05 | Pfizer-BioNTech |
Free text
Release 6 — day 14, dose 1
Symptoms: Increased fatigue and muscle soreness. Trouble sleeping.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Disoriented, unusually clumsy
Release 7 — day 14, dose 2
Symptoms: The last few days I was feeling increasingly nauseous with headaches and stomachache. Trouble sleeping and lack of focus.
Release 8 — day 28, dose 2
Symptoms: Diarrhea
Release 10 — 6 months, dose 2
Symptoms: I got tested positive for COVID-19, but have finished my 10 day isolation period. Day 3 was the worst, I woke up with chills and a cough, I could barely move. Headache and body aches, feverish, sore throat, fatigued, loss of taste and smell.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | ✓ | ✓ | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Disturbance in attention | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sleep disorder | ✓ | ✓ | ✓ |
| SRO | Clumsiness | ✓ | ✓ | ✓ |
| SRO | Disorientation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release